Semenogelin-2

BE0009916ProteinHumansSEMG2

Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. It is acted on by 2 drugs in DrugBank.

Gene name
SEMG2
UniProtKB entry
Q02383Swiss-Prot
Cellular location
Secreted
Residues / weight
582 residues · 65,444 Da
Also known as
Semenogelin II · SGII

Resolves to

Protein
UniProtQ02383UniProt nameSEMG2_HUMAN
Gene
HGNCHGNC:10743NCBI Gene6407GeneCardsSEMG2
Pharmacology
KEGGhsa:6407
Drugs

What you can answer from here — as of April 16, 2020

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
9GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Semenogelin-2, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In